/f/125658/7246x3240/f72d1f6fc5/esc-logo-lock-up-red-pos-rgb.png){kind=logo}
Jannick Dorresteijn studied Medicine (2009) and Clinical Epidemiology (2011) at Utrecht University. His PhD research focused on personalizing the treatment of cardiovascular diseases based on computational models. He conducted this research partly at Harvard University and led to a cum laude PhD at Utrecht University in 2013. He completed his training as an Internist, Specialist in Vascular Medicine at University Medical Center Utrecht, The Netherlands in 2019, and is currently still employed there. His research interests are cardiovascular prevention, prediction research, and premature atherosclerosis. Dr. Dorresteijn contributed to the development of several risk prediction apps, including https://U-Prevent.com and the ESC CVD risk calculation app. He is a member of the ESC Cardiovascular Research Collaboration working group and was listed as a final author on publications of guideline-recommended risk scores, e.g. SCORE2, SMART2, LIFE-CVD, and DIAL.
